Literature DB >> 9476865

Increased levels of elastase and alpha1-antitrypsin in sputum of asthmatic patients.

A M Vignola1, A Bonanno, A Mirabella, L Riccobono, F Mirabella, M Profita, V Bellia, J Bousquet, G Bonsignore.   

Abstract

Asthma and chronic bronchitis are inflammatory diseases associated with remodeling of the extracellular matrix (ECM). Elastin, a major component of the ECM in the airways, has been previously found to be disrupted in asthma and chronic bronchitis. This study was aimed at evaluating whether elastin disruption might be associated with an imbalance between elastase (active and total) and alpha1-proteinase inhibitor (alpha1-PI), the main inhibitor of elastase. We measured elastase and alpha1-PI in induced sputum obtained from 16 control subjects, 10 healthy smokers, 19 asthmatic patients, and 10 chronic bronchitis patients. We also assessed the possible origin of elastase, evaluating its levels in sputum with reference to differential cell counts. We found that in induced sputum obtained from asthmatic and chronic bronchitis patients, the levels of both total and active elastase were significantly increased as compared with those of control subjects and healthy smokers and were significantly correlated with the percentage of neutrophils. In addition, in asthma and chronic bronchitis patients, the levels of active and total elastase were inversely correlated with the degree of airway obstruction as assessed from FEV1 values. This study shows that airway inflammation in asthma and chronic bronchitis is associated with high levels of active elastase, which may play a role in the pathogenesis of airway remodeling.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9476865     DOI: 10.1164/ajrccm.157.2.9703070

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  23 in total

Review 1.  New evidence of inflammation in asthma.

Authors:  A M Vignola; R Gagliardo; D Guerrera; G Chiappara; P Chanez; J Bousquet; G Bonsignore
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

Review 2.  Asthma phenotypes: the evolution from clinical to molecular approaches.

Authors:  Sally E Wenzel
Journal:  Nat Med       Date:  2012-05-04       Impact factor: 53.440

Review 3.  Asthma outcomes: biomarkers.

Authors:  Stanley J Szefler; Sally Wenzel; Robert Brown; Serpil C Erzurum; John V Fahy; Robert G Hamilton; John F Hunt; Hirohito Kita; Andrew H Liu; Reynold A Panettieri; Robert P Schleimer; Michael Minnicozzi
Journal:  J Allergy Clin Immunol       Date:  2012-03       Impact factor: 10.793

Review 4.  Neutrophilic Inflammation in Asthma and Association with Disease Severity.

Authors:  Anuradha Ray; Jay K Kolls
Journal:  Trends Immunol       Date:  2017-08-04       Impact factor: 16.687

5.  Genetic influences on asthma susceptibility in the developing lung.

Authors:  Nicole Carpe; Isabel Mandeville; Leslie Ribeiro; Andre Ponton; James G Martin; Alvin T Kho; Jen-Hwa Chu; Kelan Tantisira; Scott T Weiss; Benjamin A Raby; Feige Kaplan
Journal:  Am J Respir Cell Mol Biol       Date:  2010-01-29       Impact factor: 6.914

6.  Elastase alters contractility and promotes an inflammatory synthetic phenotype in airway smooth muscle tissues.

Authors:  Angelia D Lockett; Yidi Wu; Susan J Gunst
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-12-06       Impact factor: 5.464

Review 7.  Neutrophils in asthma.

Authors:  Ana L Macdowell; Stephen P Peters
Journal:  Curr Allergy Asthma Rep       Date:  2007-11       Impact factor: 4.806

8.  Asthmatic airway neutrophilia after allergen challenge is associated with the glutathione S-transferase M1 genotype.

Authors:  Aimee Hoskins; Sara Reiss; Pingsheng Wu; Ning Chen; Wei Han; Rui-hong Do; Rasul Abdolrasulnia; Ryszard Dworski
Journal:  Am J Respir Crit Care Med       Date:  2012-11-29       Impact factor: 21.405

9.  Potent elastase inhibitors from cyanobacteria: structural basis and mechanisms mediating cytoprotective and anti-inflammatory effects in bronchial epithelial cells.

Authors:  Lilibeth A Salvador; Kanchan Taori; Jason S Biggs; Jean Jakoncic; David A Ostrov; Valerie J Paul; Hendrik Luesch
Journal:  J Med Chem       Date:  2013-01-28       Impact factor: 7.446

10.  Protease-activated receptor-2 (PAR-2) is a weak enhancer of mucin secretion by human bronchial epithelial cells in vitro.

Authors:  Ko-Wei Lin; Joungjoa Park; Anne L Crews; Yuehua Li; Kenneth B Adler
Journal:  Int J Biochem Cell Biol       Date:  2007-11-09       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.